NLRP3 and lung adenocarcinoma: Some previous studies suggested that NLRP3 downregulation inhibited EMT and metastasis in in vitro and in vivo experiments, and the targeting of NLRP3 may be a promising strategy for the treatment of lung adenocarcinoma (23).